Phase III randomised trialDouble blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients-Science-Chemical Encyclopedia-lookchem

Phase III randomised trialDouble blind randomized prospective trial of bethanechol (cas 111244-96-3) in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients
Add time:08/29/2019 Source:sciencedirect.com

This study assessed the prophylactic bethanechol (cas 111244-96-3) use to prevent salivary gland dysfunction during radiotherapy. A total of 97 head and neck cancer patients were allocated into two groups: Bethanechol or Placebo. Bethanechol group presented significantly improve of salivary parameters. Bethanechol was effective in decreasing the salivary gland damage.

We also recommend Trading Suppliers and Manufacturers of bethanechol (cas 111244-96-3). Pls Click Website Link as below: cas 111244-96-3 suppliers

Prev:Toxicological and metabolic investigations of the safety of N-α-Lauroyl-l-arginine ethyl ester monohydrochloride (LAE)
Next: Bioengineering/NanomedicineIn vitro Effect of bethanechol (cas 111244-96-3) and Suberyldicholine on Regions of Guinea Pig Esophagus)

Click to view details

Encyclopedia